ORINF
Price:
$81.3
Market Cap:
$8.61B
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asth...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-05-28
Stock Exchange
OTC
Ticker
ORINF
According to Orion Oyj’s latest financial reports and current stock price. The company's current ROE is 38.61%. This represents a change of 291.85% compared to the average of 9.85% of the last 4 quarters.
The mean historical ROE of Orion Oyj over the last ten years is 32.72%. The current 38.61% ROE has changed 18.02% with respect to the historical average. Over the past ten years (40 quarters), ORINF's ROE was at its highest in in the June 2018 quarter at 26.44%. The ROE was at its lowest in in the December 2022 quarter at 3.48%.
Average
32.72%
Median
33.04%
Minimum
24.36%
Maximum
42.72%
Discovering the peaks and valleys of Orion Oyj ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.53%
Maximum Annual ROE = 42.72%
Minimum Annual Increase = -39.82%
Minimum Annual ROE = 24.36%
| Year | ROE | Change |
|---|---|---|
| 2024 | 32.83% | 34.77% |
| 2023 | 24.36% | -36.71% |
| 2022 | 38.49% | 48.53% |
| 2021 | 25.91% | -13.83% |
| 2020 | 30.07% | 16.95% |
| 2019 | 25.71% | -39.82% |
| 2018 | 42.72% | 28.49% |
| 2017 | 33.25% | -14.39% |
| 2016 | 38.84% | 10.98% |
| 2015 | 35.00% | -14.72% |
The current ROE of Orion Oyj (ORINF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.89%
5-year avg
30.33%
10-year avg
32.72%
Orion Oyj’s ROE is less than CSPC Pharmaceutical Group Limited (13.36%), less than CSPC Pharmaceutical Group Limited (13.36%), less than Recordati Industria Chimica e Farmaceutica S.p.A. (21.43%), greater than Swedish Orphan Biovitrum AB (publ) (0.03%), less than Grifols, S.A. (5.40%), less than Bangkok Dusit Medical Services Public Company Limited (16.33%), less than Eurofins Scientific SE (6.20%), less than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (6.89%), less than Grifols, S.A. (5.40%), less than Kyowa Kirin Co., Ltd. (4.57%),
| Company | ROE | Market cap |
|---|---|---|
| 13.36% | $11.10B | |
| 13.36% | $10.85B | |
| 21.43% | $13.38B | |
| 0.03% | $12.15B | |
| 5.40% | $7.93B | |
| 16.33% | $12.84B | |
| 6.20% | $12.07B | |
| 6.89% | $8.75B | |
| 5.40% | $8.66B | |
| 4.57% | $7.93B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orion Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orion Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Orion Oyj's ROE?
How is the ROE calculated for Orion Oyj (ORINF)?
What is the highest ROE for Orion Oyj (ORINF)?
What is the 3-year average ROE for Orion Oyj (ORINF)?
What is the 5-year average ROE for Orion Oyj (ORINF)?
How does the current ROE for Orion Oyj (ORINF) compare to its historical average?